Login/Sign Up
Telbicure-M Tablet ER
₹156.15*
MRP ₹173.5
10% off
₹147.5*
MRP ₹173.5
15% CB
₹26 cashback(15%)
Free Delivery
With Circle membership
(Inclusive of all Taxes)
This offer price is valid on orders above ₹800. Apply coupon PHARMA10/PHARMA18 (excluding restricted items)
Provide Delivery Location
Whats That
Telbicure-M Tablet ER belongs to the class antihypertensive agents used to treat hypertension (high blood pressure). It may also be used to lower the risk of heart attack and stroke in future. High blood pressure is a condition in which the force of the blood against the artery walls is too high leading to hypertension. Symptoms of high blood pressure include headache, dizziness, nose bleed, changes in vision, chest pain, weakness and dyspnoea (shortness of breath).
Telbicure-M Tablet ER is a combination of two high blood pressure-lowering medicines: Telmisartan and Metoprolol succinate. Telmisartan belongs to the class of drugs called Angiotensin II receptor antagonists that works by blocking the angiotensin II receptor, relaxing the blood vessels and lowering the blood pressure. Metoprolol succinate belongs to the class of drugs known as beta-blockers which reduces blood pressure by allowing the blood to flow more smoothly. Together, Telbicure-M Tablet ER helps in reducing the raised blood pressure.
Take Telbicure-M Tablet ER as prescribed. You are advised to take Telbicure-M Tablet ER for as long as your doctor has prescribed it for you, depending on your medical condition. In some cases, you may experience certain common side effects such as headache, nausea, dizziness, weakness, stomach pain, and slow heart rate. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects persistently.
To treat your condition effectually, continue taking Telbicure-M Tablet ER for as long as your doctor has prescribed it. Try not to stop taking it on your own as it may cause a sudden increase the blood pressure, chest pain or heart attack. Consult your doctor before starting Telbicure-M Tablet ER if you are pregnant or breastfeeding. Telbicure-M Tablet ER may cause dizziness, so drive only if you are alert. Avoid alcohol consumption with Telbicure-M Tablet ER as it may cause increased dizziness. Keep your doctor informed about your health condition and medications to rule out any interactions.
Telbicure-M Tablet ER is a combination of two blood pressure-lowering medicines: Telmisartan and Metoprolol succinate. Telmisartan belongs to the class of drugs called Angiotensin II receptor antagonists. It works by blocking the angiotensin II receptor, thereby relaxing the blood vessels and lowering the blood pressure. Metoprolol succinate belongs to the class of drugs known as beta-blockers. It helps to reduce blood pressure by allowing the blood to flow more smoothly. Together, Telbicure-M Tablet ER helps in lowering blood pressure to normal.
Do not take Telbicure-M Tablet ER if you are allergic to telmisartan or metoprolol succinate. Inform your doctor if you are taking monoamine oxidase inhibitors, aliskiren, quinidine, disopyramide, or other blood pressure-lowering medicines. Pregnant and breastfeeding women should consult their doctor before taking Telbicure-M Tablet ER. Telbicure-M Tablet ER is not recommended for children. Telbicure-M Tablet ER may cause dizziness and tiredness, so drive or operate heavy machinery only if you are alert. Keep your doctor informed if you have kidney or liver diseases, biliary obstruction, heart problems, low blood pressure, diabetes, elevated potassium levels, blood circulation problems, asthma, COPD, metabolic acidosis, phaeochromocytoma, slow heart rate, psoriasis, myasthenia gravis, or prinzmetal angina.
Drug-Drug Interactions: Telbicure-M Tablet ER may have interaction with medicines used to treat pain (aspirin, ibuprofen), anti-seizure (pregabalin), heart-related medicines (digoxin, flecainide), anti-depression drugs (lithium, fluvoxamine, sertraline, fluoxetine), and drugs used to treat erectile dysfunction (sildenafil).
Drug-Food Interactions: Maintain low salt and low-fat diet while taking Telbicure-M Tablet ER. Avoid consuming food rich in potassium, such as potassium-containing salt substitutes or over-the-counter potassium supplements. Avoid smoking and alcohol consumption.
Drug-Disease Interactions: Telbicure-M Tablet ER may have interactions with disease conditions such as diabetes, renal dysfunction (kidney disease), pulmonary disease, alcoholism, congestive heart failure (heart disease), hypotension (low blood pressure) and liver disease.
High blood pressure (hypertension): It is a condition in which the blood exerts increased pressure on the walls of blood vessels leading to hypertension. This condition can lead to hardened arteries (blood vessels), decreasing the blood and oxygen flow to the heart. Raised blood pressure can cause chest pain (angina) and heart attack (when blood supply to the heart is blocked). Additionally, high blood pressure also causes brain damage (stroke) and kidney failure. Symptoms of high blood pressure include headache, dizziness, nose bleed, changes in vision, chest pain, weakness and dyspnoea (shortness of breath). However, most of the time, the signs and symptoms of hypertension are none.
Alcohol
Unsafe
You are recommended to avoid alcohol consumption while taking Telbicure-M Tablet ER as it might cause increased dizziness. Alcohol intake might interfere with the working of Telbicure-M Tablet ER.
Pregnancy
Unsafe
It is not recommended to take Telbicure-M Tablet ER while you are pregnant. Please consult your doctor.
Breast Feeding
Unsafe
It is not recommended to take Telbicure-M Tablet ER while you are breastfeeding. Please consult your doctor. Your doctor will decide whether Telbicure-M Tablet ER can be given to breastfeeding mothers or not.
Driving
Caution
Telbicure-M Tablet ER may cause dizziness, do not drive or operate heavy machinery if you feel dizzy.
Liver
Caution
Dose adjustment may be needed. Telbicure-M Tablet ER should be used with caution in patients with liver impairment/liver disease.
Kidney
Caution
Dose adjustment may be needed. Telbicure-M Tablet ER should be used with caution in patients with kidney impairment/kidney disease.
Children
Unsafe
Telbicure-M Tablet ER is not recommended for children below 18years as the safety and effectiveness have not been established.
Country of origin
We provide you with authentic, trustworthy and relevant information
Product Substitutes